What's Happening?
Lancôme has launched the Absolue Longevity MD Collection, a skincare line designed to address the biological signs of aging. The collection is powered by Mitopure, a compound developed by the Swiss biotech company Timeline, which is clinically proven
to enhance mitochondrial function in skin cells. This innovation aims to reduce fine lines, support collagen production, and improve skin resilience. The collection is divided into three ranges: Anticipate, Intercept, and Reset, each targeting different stages of skin aging. Ramzy Burns, general manager of Lancôme US, highlights the shift in skincare focus from chronological age to visible biological age, emphasizing a personalized approach to skincare.
Why It's Important?
The introduction of the Absolue Longevity MD Collection marks a significant shift in the skincare industry towards personalized and scientifically-backed products. By focusing on biological rather than chronological age, Lancôme is addressing the growing consumer demand for tailored skincare solutions. This approach not only caters to individual needs but also positions Lancôme as a leader in innovative skincare. The use of Mitopure, a patented ingredient, underscores the brand's commitment to leveraging scientific advancements to enhance product efficacy. This development could influence other skincare brands to adopt similar strategies, potentially reshaping industry standards.
